{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:03:45Z","timestamp":1772136225677,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vaccine and Infectious Disease Organization"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein misfolding and aggregation play crucial roles in amyloidogenic diseases through the self-assembly of intrinsically disordered proteins (IDPs) in type II diabetes (T2D), Alzheimer's disease (AD) and Parkinson\u2019s disease (PD). PD is the most common neurodegenerative disorder after AD, and is associated with the loss of dopaminergic signaling, which causes motor and nonmotor signs and symptoms. Lewy bodies and Lewy neurites are common pathological hallmarks of PD that are mainly composed of aggregates of disordered \u03b1-synuclein (\u03b1-Syn). There have been many efforts to develop chemical compounds to prevent aggregation or facilitate disruption of the aggregates. Furthermore, the roles and interactions of many compounds have yet to be revealed at the atomistic level, especially their impacts on the dynamics and chain-chain interactions of the oligomers, which are of interest in this study. The conformational diversity and detailed interactions among homo-oligomer chains of \u03b1-Syn are not fully discovered; identifying these might help uncover a practical approach to developing a potent therapy. In this study, we used an in-silico investigation to address the conformational diversity of \u03b1-Syn oligomer. The roles of several point mutations in protein aggregation in PD are known; we take this further by evaluating the interaction energies and contributions of all residues in stability and residue-chain interactions. In this study, we docked chemical derivatives of three compounds with high drug-likeness properties to evaluate the roles of our ligands in the conformational dynamicity of the oligomers, with emphasis on intramolecular forces. Free energy evaluation of the modeled inter and intramolecular interactions through MD simulation shows effective interaction and binding between \u03b1-Syn and our compounds. However, we find that they do not significantly disrupt the chain-chain interactions, compared to unliganded simulation.<\/jats:p>","DOI":"10.1038\/s41598-023-46181-1","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T09:03:15Z","timestamp":1699002195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Conformational dynamics of \u03b1-synuclein and study of its intramolecular forces in the presence of selected compounds"],"prefix":"10.1038","volume":"13","author":[{"given":"Zahed","family":"Khatooni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keivan","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"issue":"7660","key":"46181_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer, D. et al. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 546(7660), 656\u2013661 (2017).","journal-title":"Nature."},{"issue":"9996","key":"46181_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386(9996), 896\u2013912 (2015).","journal-title":"Lancet"},{"issue":"9","key":"46181_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21093301","volume":"21","author":"A Mori","year":"2020","unstructured":"Mori, A., Imai, Y. & Hattori, N. Lipids: Key players that modulate \u03b1-synuclein toxicity and neurodegeneration in Parkinson\u2019s disease. Int. J. Mol. Sci. 21(9), 1\u201310 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"46181_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12035-021-02596-3","volume":"59","author":"IN Serratos","year":"2022","unstructured":"Serratos, I. N., Hern\u00e1ndez-P\u00e9rez, E., Campos, C., Aschner, M. & Santamar\u00eda, A. An update on the critical role of \u03b1-synuclein in Parkinson\u2019s disease and other synucleinopathies: From tissue to cellular and molecular levels. Mol. Neurobiol. 59(1), 620\u2013642 (2022).","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"46181_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel, H. A., Overk, C. R., Oueslati, A. & Masliah, E. The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14(1), 38\u201348 (2013).","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"46181_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","volume":"14","author":"A Iwai","year":"1995","unstructured":"Iwai, A. et al. The precursor protein of non-A\u03b2 component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14(2), 467\u2013475 (1995).","journal-title":"Neuron."},{"issue":"11","key":"46181_CR7","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R., Jakes, R., Hasegawa, M. & Goedert, M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. 95(11), 6469\u20136473 (1998).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5321","key":"46181_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science. 276(5321), 2045\u20132047 (1997).","journal-title":"Science."},{"issue":"7","key":"46181_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22(7), 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"issue":"2","key":"46181_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.expneurol.2009.08.032","volume":"223","author":"KA DaSilva","year":"2010","unstructured":"DaSilva, K. A., Shaw, J. E. & McLaurin, J. Amyloid-\u03b2 fibrillogenesis: Structural insight and therapeutic intervention. Exp. Neurol. 223(2), 311\u2013321 (2010).","journal-title":"Exp. Neurol."},{"key":"46181_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108843","volume":"115","author":"Z Wang","year":"2019","unstructured":"Wang, Z., Gao, G., Duan, C. & Yang, H. Progress of immunotherapy of anti-\u03b1-synuclein in Parkinson\u2019s disease. Biomed. Pharmacother. 115, 108843 (2019).","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"46181_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/neup.12812","volume":"42","author":"C-J Choong","year":"2022","unstructured":"Choong, C.-J. & Mochizuki, H. Neuropathology of \u03b1-synuclein in Parkinson\u2019s disease. Neuropathology. 42(2), 93\u2013103 (2022).","journal-title":"Neuropathology."},{"key":"46181_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.euprot.2016.02.003","volume":"11","author":"F Lavatelli","year":"2016","unstructured":"Lavatelli, F., di Fonzo, A., Palladini, G. & Merlini, G. Systemic amyloidoses and proteomics: The state of the art. EuPA Open Proteom. 11, 4\u201310 (2016).","journal-title":"EuPA Open Proteom."},{"issue":"36","key":"46181_CR14","doi-asserted-by":"publisher","first-page":"17963","DOI":"10.1073\/pnas.1906124116","volume":"116","author":"K Araki","year":"2019","unstructured":"Araki, K. et al. Parkinson\u2019s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of \u03b1-synuclein. Proc. Natl. Acad. Sci. 116(36), 17963\u201317969 (2019).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"46181_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle, M. D. et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat. Struct. Mol. Biol. 23(5), 409\u2013415 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"9","key":"46181_CR16","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.str.2021.05.002","volume":"29","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. The structural heterogeneity of \u03b1-synuclein is governed by several distinct subpopulations with interconversion times slower than milliseconds. Structure. 29(9), 1048\u20131064 (2021).","journal-title":"Structure."},{"issue":"1","key":"46181_CR17","doi-asserted-by":"publisher","first-page":"8337","DOI":"10.1038\/s41598-018-26645-5","volume":"8","author":"L Palazzi","year":"2018","unstructured":"Palazzi, L. et al. Oleuropein aglycone stabilizes the monomeric \u03b1-synuclein and favours the growth of non-toxic aggregates. Sci. Rep. 8(1), 8337 (2018).","journal-title":"Sci. Rep."},{"issue":"18","key":"46181_CR18","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","volume":"27","author":"JM Ellis","year":"2017","unstructured":"Ellis, J. M. & Fell, M. J. Current approaches to the treatment of Parkinson\u2019s disease. Bioorg. Med. Chem. Lett. 27(18), 4247\u20134255 (2017).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"46181_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2018.01555","volume":"9","author":"H Javed","year":"2019","unstructured":"Javed, H. et al. Plant extracts and phytochemicals targeting \u03b1-synuclein aggregation in Parkinson\u2019s disease models. Front. Pharmacol. 9, 1\u201310 (2019).","journal-title":"Front. Pharmacol."},{"issue":"1","key":"46181_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","volume":"103","author":"VN Uversky","year":"2007","unstructured":"Uversky, V. N. Neuropathology, biochemistry, and biophysics of \u03b1-synuclein aggregation. J. Neurochem. 103(1), 17\u201337 (2007).","journal-title":"J. Neurochem."},{"issue":"23","key":"46181_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167855","volume":"434","author":"AL Gr\u00f8nnemose","year":"2022","unstructured":"Gr\u00f8nnemose, A. L., \u00d8sterlund, E. C., Otzen, D. E. & J\u00f8rgensen, T. J. D. EGCG has dual and opposing effects on the N-terminal region of self-associating \u03b1-synuclein oligomers. J. Mol. Biol. 434(23), 167855 (2022).","journal-title":"J. Mol. Biol."},{"issue":"11","key":"46181_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1021\/acs.biochem.2c00160","volume":"61","author":"HM Sanders","year":"2022","unstructured":"Sanders, H. M., Kostelic, M. M., Zak, C. K. & Marty, M. T. Lipids and EGCG affect \u03b1-synuclein association and disruption of nanodiscs. Biochemistry 61(11), 1014\u20131021 (2022).","journal-title":"Biochemistry"},{"issue":"2","key":"46181_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1381612822666151112151653","volume":"22","author":"A Sarrafchi","year":"2016","unstructured":"Sarrafchi, A., Bahmani, M., Shirzad, H. & Rafieian-Kopaei, M. Oxidative stress and Parkinson\u2019s disease: new hopes in treatment with herbal antioxidants. Curr. Pharm. Des. 22(2), 238\u2013246 (2016).","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"46181_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/ptr.5834","volume":"31","author":"ZY Wang","year":"2017","unstructured":"Wang, Z. Y. et al. Neuroprotective natural products for the treatment of Parkinson\u2019s disease by targeting the autophagy\u2013lysosome pathway: A systematic review. Phytother. Res. 31(8), 1119\u20131127 (2017).","journal-title":"Phytother. Res."},{"key":"46181_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fneur.2018.00295","volume":"9","author":"V Ghiglieri","year":"2018","unstructured":"Ghiglieri, V., Calabrese, V. & Calabresi, P. Alpha-synuclein: From early synaptic dysfunction to neurodegeneration. Front. Neurol. 9, 295 (2018).","journal-title":"Front. Neurol."},{"issue":"4","key":"46181_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/0929866525666180326120052","volume":"25","author":"K Broersen","year":"2018","unstructured":"Broersen, K., Ruiperez, V. & Davletov, B. Structural and aggregation properties of alpha-synuclein linked to phospholipase A2 action. Protein Peptide Lett. 25(4), 368\u2013378 (2018).","journal-title":"Protein Peptide Lett."},{"issue":"26","key":"46181_CR27","doi-asserted-by":"publisher","first-page":"26868","DOI":"10.1074\/jbc.M402379200","volume":"279","author":"WJ Goux","year":"2004","unstructured":"Goux, W. J. et al. The formation of straight and twisted filaments from short tau peptides. J. Biol. Chem. 279(26), 26868\u201326875 (2004).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"46181_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/biom11060897","volume":"11","author":"O Kosz\u0142a","year":"2021","unstructured":"Kosz\u0142a, O. et al. Current approaches and tools used in drug development against parkinson\u2019s disease. Biomolecules 11(6), 897 (2021).","journal-title":"Biomolecules"},{"key":"46181_CR29","first-page":"1179","volume":"2011","author":"G Skibinski","year":"2011","unstructured":"Skibinski, G. & Finkbeiner, S. Drug discovery in Parkinson\u2019s disease-Update and developments in the use of cellular models. Int. J. High Throughput Screen. 2011, 1179\u20131381 (2011).","journal-title":"Int. J. High Throughput Screen."},{"key":"46181_CR30","doi-asserted-by":"publisher","first-page":"977521","DOI":"10.3389\/fphar.2022.977521","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang, Y. et al. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson\u2019s disease. Front. Pharmacol. 13, 977521 (2022).","journal-title":"Front. Pharmacol."},{"issue":"42","key":"46181_CR31","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acs.jafc.9b04558","volume":"67","author":"F Liu","year":"2019","unstructured":"Liu, F. et al. Brazilin inhibits \u03b1-synuclein fibrillogenesis, disrupts mature fibrils, and protects against amyloid-induced cytotoxicity. J. Agric. Food Chem. 67(42), 11769\u201311777 (2019).","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"46181_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/cn3001203","volume":"4","author":"PK Singh","year":"2013","unstructured":"Singh, P. K. et al. Curcumin modulates \u03b1-synuclein aggregation and toxicity. ACS Chem. Neurosci. 4(3), 393\u2013407 (2013).","journal-title":"ACS Chem. Neurosci."},{"issue":"21","key":"46181_CR33","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1021\/acschemneuro.1c00379","volume":"12","author":"B Saffari","year":"2021","unstructured":"Saffari, B. & Amininasab, M. Crocin inhibits the fibrillation of human \u03b1-synuclein and disassembles mature fibrils: Experimental findings and mechanistic insights from molecular dynamics simulation. ACS Chem. Neurosci. 12(21), 4037\u20134057 (2021).","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"46181_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094796","volume":"9","author":"Q Wang","year":"2014","unstructured":"Wang, Q., Guo, J., Jiao, P., Liu, H. & Yao, X. Exploring the influence of EGCG on the \u03b2-sheet-rich oligomers of human islet amyloid polypeptide (hIAPP1\u201337) and identifying its possible binding sites from molecular dynamics simulation. PLoS ONE 9(4), e94796 (2014).","journal-title":"PLoS ONE"},{"issue":"6","key":"46181_CR35","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3390\/molecules23061297","volume":"23","author":"M Pervin","year":"2018","unstructured":"Pervin, M. et al. Beneficial effects of green tea catechins on neurodegenerative diseases. Molecules 23(6), 1297 (2018).","journal-title":"Molecules"},{"key":"46181_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123194","volume":"230","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. EGCG attenuates \u03b1-synuclein protofibril-membrane interactions and disrupts the protofibril. Int. J. Biol. Macromol. 230, 123194 (2023).","journal-title":"Int. J. Biol. Macromol."},{"issue":"52","key":"46181_CR37","doi-asserted-by":"publisher","first-page":"32508","DOI":"10.1039\/C7RA03752J","volume":"7","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. (\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity. RSC Adv. 7(52), 32508\u201332517 (2017).","journal-title":"RSC Adv."},{"issue":"3","key":"46181_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biom12030371","volume":"12","author":"A Payne","year":"2022","unstructured":"Payne, A., Nahashon, S., Taka, E., Adinew, G. M. & Soliman, K. F. Epigallocatechin-3-Gallate (EGCG): New therapeutic perspectives for neuroprotection, aging, and neuroinflammation for the modern age. Biomolecules 12(3), 371 (2022).","journal-title":"Biomolecules"},{"issue":"11","key":"46181_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/bph.13649","volume":"174","author":"I Peluso","year":"2017","unstructured":"Peluso, I. & Serafini, M. Antioxidants from black and green tea: From dietary modulation of oxidative stress to pharmacological mechanisms. Br. J. Pharmacol. 174(11), 1195\u20131208 (2017).","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"46181_CR40","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.1073\/pnas.0910723107","volume":"107","author":"J Bieschke","year":"2010","unstructured":"Bieschke, J. et al. EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. 107(17), 7710\u20137715 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"46181_CR41","doi-asserted-by":"publisher","first-page":"9595","DOI":"10.1074\/jbc.M411805200","volume":"280","author":"TS Ulmer","year":"2005","unstructured":"Ulmer, T. S., Bax, A., Cole, N. B. & Nussbaum, R. L. Structure and dynamics of micelle-bound human \u03b1-synuclein. J. Biol. Chem. 280(10), 9595\u20139603 (2005).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"46181_CR42","doi-asserted-by":"publisher","first-page":"24526","DOI":"10.1038\/srep24526","volume":"6","author":"L Pieri","year":"2016","unstructured":"Pieri, L., Madiona, K. & Melki, R. Structural and functional properties of prefibrillar \u03b1-synuclein oligomers. Sci. Rep. 6(1), 24526 (2016).","journal-title":"Sci. Rep."},{"issue":"41","key":"46181_CR43","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols, J. et al. Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc. Natl. Acad. Sci. 115(41), 10481\u201310486 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"46181_CR44","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1021\/acsptsci.2c00104","volume":"5","author":"E Angelopoulou","year":"2022","unstructured":"Angelopoulou, E., Paudel, Y. N., Papageorgiou, S. G. & Piperi, C. Elucidating the beneficial effects of ginger (Zingiber officinale Roscoe) in Parkinson\u2019s disease. ACS Pharmacol. Transl. Sci. 5(10), 838\u2013848 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"1","key":"46181_CR45","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1186\/1471-2105-12-S1-S33","volume":"12","author":"K-C Hsu","year":"2011","unstructured":"Hsu, K.-C., Chen, Y.-F., Lin, S.-R. & Yang, J.-M. iGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinform. 12(1), S33 (2011).","journal-title":"BMC Bioinform."},{"key":"46181_CR46","unstructured":"Spoel LAHvd. GROMACS 2021.5. (2021)."},{"key":"46181_CR47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 1\u20132, 19\u201325 (2015).","journal-title":"SoftwareX."},{"issue":"1","key":"46181_CR48","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nat. Methods. 14(1), 71\u201373 (2017).","journal-title":"Nat. Methods."},{"issue":"9","key":"46181_CR49","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 8(9), 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"issue":"3","key":"46181_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-014-9713-7","volume":"28","author":"KB Koziara","year":"2014","unstructured":"Koziara, K. B., Stroet, M., Malde, A. K. & Mark, A. E. Testing and validation of the Automated Topology Builder (ATB) version 2.0: Prediction of hydration free enthalpies. J. Comput. Aided Mol. Des. 28(3), 221\u2013233 (2014).","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"12","key":"46181_CR51","doi-asserted-by":"publisher","first-page":"10089","DOI":"10.1063\/1.464397","volume":"98","author":"T Darden","year":"1993","unstructured":"Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 98(12), 10089\u201310092 (1993).","journal-title":"J. Chem. Phys."},{"issue":"1","key":"46181_CR52","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126(1), 014101 (2007).","journal-title":"J. Chem. Phys."},{"issue":"8","key":"46181_CR53","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81(8), 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."},{"issue":"12","key":"46181_CR54","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 52(12), 7182\u20137190 (1981).","journal-title":"J. Appl. Phys."},{"issue":"7","key":"46181_CR55","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R. & Lynn, A. g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J. Chem. Inform. Model. 54(7), 1951\u20131962 (2014).","journal-title":"J. Chem. Inform. Model."},{"issue":"18","key":"46181_CR56","doi-asserted-by":"publisher","first-page":"10037","DOI":"10.1073\/pnas.181342398","volume":"98","author":"NA Baker","year":"2001","unstructured":"Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. 98(18), 10037 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"46181_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski, C. A. Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov. Today Technol. 1(4), 337\u2013341 (2004).","journal-title":"Drug Discov. Today Technol."},{"issue":"17","key":"46181_CR58","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1471-2105-13-S17-S7","volume":"13","author":"B Jayaram","year":"2012","unstructured":"Jayaram, B. et al. Sanjeevini: A freely accessible web-server for target directed lead molecule discovery. BMC Bioinform. 13(17), S7 (2012).","journal-title":"BMC Bioinform."},{"issue":"1","key":"46181_CR59","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 42717 (2017).","journal-title":"Sci. Rep."},{"issue":"12","key":"46181_CR60","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1021\/ci500467k","volume":"54","author":"A Daina","year":"2014","unstructured":"Daina, A., Michielin, O. & Zoete, V. iLOGP: A simple, robust, and efficient description of n-octanol\/water partition coefficient for drug design using the GB\/SA approach. J. Chem. Inf. Model. 54(12), 3284\u20133301 (2014).","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"46181_CR61","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina, A. & Zoete, V. A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 11(11), 1117\u20131121 (2016).","journal-title":"ChemMedChem."},{"issue":"5","key":"46181_CR62","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/bioinformatics\/btp023","volume":"25","author":"LW Yang","year":"2009","unstructured":"Yang, L. W., Eyal, E., Bahar, I. & Kitao, A. Principal component analysis of native ensembles of biomolecular structures (PCA_NEST): Insights into functional dynamics. Bioinformatics 25(5), 606\u2013614 (2009).","journal-title":"Bioinformatics"},{"key":"46181_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1574-1400(06)02013-5","volume":"2","author":"SAM Stein","year":"2006","unstructured":"Stein, S. A. M., Loccisano, A. E., Firestine, S. M. & Evanseck, J. D. Principal components analysis: A review of its application on molecular dynamics data. Annu. Rep. Comput. Chem. 2, 233\u2013261 (2006).","journal-title":"Annu. Rep. Comput. Chem."},{"issue":"2\u20133","key":"46181_CR64","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jmb.2012.02.004","volume":"421","author":"D Matthes","year":"2012","unstructured":"Matthes, D., Gapsys, V. & de Groot, B. L. Driving forces and structural determinants of steric zipper peptide oligomer formation elucidated by atomistic simulations. J. Mol. Biol. 421(2\u20133), 390\u2013416 (2012).","journal-title":"J. Mol. Biol."},{"key":"46181_CR65","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/B0-08-045044-X\/00147-4","volume-title":"Comprehensive Medicinal Chemistry II","author":"JV Turner","year":"2007","unstructured":"Turner, J. V. & Agatonovic-Kustrin, S. In silico prediction of oral bioavailability. In Comprehensive Medicinal Chemistry II (eds Taylor, J. B. & Triggle, D. J.) 699\u2013724 (Elsevier, 2007)."},{"key":"46181_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2021.107963","volume":"107","author":"M Rezaei Kamelabad","year":"2021","unstructured":"Rezaei Kamelabad, M., Jahanbin Sardroodi, J., Rastkar Ebrahimzadeh, A. & Ajamgard, M. Influence of curcumin and rosmarinic acid on disrupting the general properties of Alpha-Synuclein oligomer: Molecular dynamics simulation. J. Mol. Graph. Model. 107, 107963 (2021).","journal-title":"J. Mol. Graph. Model."},{"key":"46181_CR67","doi-asserted-by":"publisher","first-page":"910104","DOI":"10.3389\/fmolb.2022.910104","volume":"9","author":"A Guzzo","year":"2022","unstructured":"Guzzo, A. et al. Wild-type \u03b1-Synuclein and variants occur in different disordered dimers and pre-Fibrillar conformations in early stage of aggregation. Front. Mol. Biosci. 9, 910104 (2022).","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"46181_CR68","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","volume":"102","author":"L Pieri","year":"2012","unstructured":"Pieri, L., Madiona, K., Bousset, L. & Melki, R. Fibrillar \u03b1-synuclein and huntingtin exon 1 assemblies are toxic to the cells. Biophys. J. 102(12), 2894\u20132905 (2012).","journal-title":"Biophys. J."},{"issue":"5","key":"46181_CR69","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149(5), 1048\u20131059 (2012).","journal-title":"Cell"},{"issue":"26","key":"46181_CR70","doi-asserted-by":"publisher","first-page":"26846","DOI":"10.1074\/jbc.M403129200","volume":"279","author":"M Zhu","year":"2004","unstructured":"Zhu, M. et al. The flavonoid baicalein inhibits fibrillation of \u03b1-synuclein and disaggregates existing fibrils. J. Biol. Chem. 279(26), 26846\u201326857 (2004).","journal-title":"J. Biol. Chem."},{"issue":"26","key":"46181_CR71","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1021\/bi030086j","volume":"42","author":"MJ Volles","year":"2003","unstructured":"Volles, M. J. & Lansbury, P. T. Zeroing in on the pathogenic form of \u03b1-synuclein and its mechanism of neurotoxicity in Parkinson\u2019s disease. Biochemistry 42(26), 7871\u20137878 (2003).","journal-title":"Biochemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46181-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46181-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46181-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T10:07:38Z","timestamp":1699006058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46181-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46181"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46181-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3137135\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"4 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19020"}}